PEG-Intron, a longer-acting form of Intron-A for treating chronic hepatitis C

February 2001

Schering is now introducing PEG-Intron, a longer-acting form of Intron-A for treating chronic hepatitis C.

PEG-Intron is the first "pegylated" interferon.

It's made by linking polyethylene glycol (PEG) to Intron-A (interferon alfa-2b). PEG slows the metabolism of the interferon to make it longer-acting.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber's Letter includes:

12 issues every year, with brief articles about new meds and guidelines
48+ CE courses, including the popular CE-in-the-Letter
Quick reference drug comparison charts
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

glucosamine supplements might slow the progression of osteoarthritis
Diabetes Starlix (nateglinide), a new oral tablet for type 2 diabetes
Diabetes statins reduce the risk of developing diabetes
Infectious Diseases new pediatric immunization schedule
Infectious Diseases longer needle to make sure vaccines are injected into the muscle
Infectious Diseases PEG-Intron, a longer-acting form of Intron-A for treating chronic hepatitis C
when to use inhaled steroids for COPD
Dermatology new ointment for eczema called Protopic
Gastroenterology too many hospital patients get acid-suppressing drugs
Gastroenterology Probiotica, a new dietary supplement for "GI health"
Women's Health Femara (letrozole) or Arimidex (anastrozole) for breast cancer
antidepressants to help patients taper off benzodiazepines
treating depression in children
Cardiology new IV anticoagulant, Angiomax (bivalirudin)
Substance Use Disorder concerns about people abusing Ritalin and OxyContin
Migraine ACE inhibitors can PREVENT migraines
Migraine valproate to TREAT migraines

PEG-Intron, a longer-acting form of Intron-A for treating chronic hepatitis C

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Table of Contents